Evidence map›Paper›PMID 30622673›Full record

ArticleOxidative medicine and cellular longevity2018

Effects of Valproate Monotherapy on the Oxidant-Antioxidant Status in Mexican Epileptic Children: A Longitudinal Study.

Eduardo Beltrán-Sarmiento, Cindy K Arregoitia-Sarabia, Esaú Floriano-Sánchez, Roberto Sandoval-Pacheco, Diana E Galván-Hernández, Elvia Coballase-Urrutia, Liliana Carmona-Aparicio, Eduardo Ramos-Reyna, Juan Rodríguez-Silverio, Noemí Cárdenas-Rodríguez

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Beyond epilepsy: The expanding role of valproic acid in Alzheimer disease therapy - a review.The Journal of pharmacology and experimental therapeutics · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Levetiracetam Mechanisms of Action: From Molecules to Systems.Pharmaceuticals (Basel, Switzerland) · 2022
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Eduardo Beltrán-SarmientoNational Institute of Pediatrics, Laboratory of Neurosciences, 04530, Mexico.
Cindy K Arregoitia-SarabiaNational Institute of Pediatrics, Laboratory of Neurosciences, 04530, Mexico.ORCID 0000-0002-2912-8070
Esaú Floriano-SánchezUniversity of the Army and Air Force, Secretary of National Defense, Military Graduate School of Health, 11200, Mexico.ORCID 0000-0001-6309-5447
Roberto Sandoval-PachecoUniversity of the Army and Air Force, Secretary of National Defense, Military Graduate School of Health, 11200, Mexico.ORCID 0000-0003-1866-1547
Diana E Galván-HernándezUniversity of the Army and Air Force, Secretary of National Defense, Military Graduate School of Health, 11200, Mexico.ORCID 0000-0002-7642-5246
Elvia Coballase-UrrutiaNational Institute of Pediatrics, Laboratory of Neurosciences, 04530, Mexico.ORCID 0000-0002-1309-0784
Liliana Carmona-AparicioNational Institute of Pediatrics, Laboratory of Neurosciences, 04530, Mexico.ORCID 0000-0001-8721-9387
Eduardo Ramos-ReynaUniversity of the Army and Air Force, Secretary of National Defense, Military Graduate School of Health, 11200, Mexico.ORCID 0000-0002-2661-2211
Juan Rodríguez-SilverioNational Polytechnic Institute, Section of Research and Graduate Studies, Mexico 11340, Mexico.ORCID 0000-0002-8998-1196
Noemí Cárdenas-RodríguezNational Institute of Pediatrics, Laboratory of Neurosciences, 04530, Mexico.ORCID 0000-0002-6580-3440
Tecnológico Nacional de México · MXVietnam National Children's Hospital · VN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epilepsy is a neurological disorder that can produce brain injury and neuronal death. Several factors such as oxidative stress have been implicated in epileptogenesis. Valproic acid (VPA) is a widely used drug for the treatment of epilepsy, but the mechanisms underlying these benefits are complex and still not fully understood. The objective of this study was to evaluate, for the first time, the effects of VPA on the oxidant-antioxidant status in Mexican epileptic children before and after 6 or 12 months of treatment with VPA by determining the activities of several plasmatic antioxidant enzymes (glutathione reductase (GR), glutathione peroxidase (GPx), superoxide dismutase (SOD), and catalase (CAT)) and oxidant marker (malondialdehyde (MDA), hydrogen peroxide (H

Indexed as

AdolescentAntioxidantsChildChild, PreschoolEpilepsyFemaleHumansLongitudinal StudiesMaleMexicoValproic AcidAntioxidantsValproic Acid

Identifiers

PMID30622673
PMCPMC6304806
OpenAlexW2902609381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.